164 related articles for article (PubMed ID: 8925630)
1. Partial stunning in thyroid remnant after administration of scanning dose followed by 100 mCi I-131 therapy.
Yagcloglu H; Ozalp E; Ibis E; Aras G
Clin Nucl Med; 1996 Apr; 21(4):340. PubMed ID: 8925630
[No Abstract] [Full Text] [Related]
2. Thyroid remnant ablation in patients with papillary cancer: a comparison of low, moderate, and high activities of radioiodine.
Kusacic Kuna S; Samardzic T; Tesic V; Medvedec M; Kuna K; Bracic I; Despot M; Dodig D
Nucl Med Commun; 2009 Apr; 30(4):263-9. PubMed ID: 19247212
[TBL] [Abstract][Full Text] [Related]
3. Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma.
Silberstein EB
J Nucl Med; 2007 Jul; 48(7):1043-6. PubMed ID: 17574976
[TBL] [Abstract][Full Text] [Related]
4. Artifactual I-131 activity in the hairs after thyroid remnant ablation.
Bhargava P; Choi WS
Thyroid; 2006 Nov; 16(11):1187-9. PubMed ID: 17123350
[No Abstract] [Full Text] [Related]
5. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
Gerard SK; Dam HQ
Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
[No Abstract] [Full Text] [Related]
6. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
Dam HQ; Kim SM; Lin HC; Intenzo CM
Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
[TBL] [Abstract][Full Text] [Related]
7. [Iodine scintigraphy of differentiated thyroid carcinoma].
Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
[No Abstract] [Full Text] [Related]
8. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
Zakavi SR; Kakhki VD
Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
[No Abstract] [Full Text] [Related]
9. Tumor thrombus in the great veins from papillary carcinoma of the thyroid: 131I scan findings.
Mugunthan N; Kumar AR; Thomas P
J Clin Endocrinol Metab; 2010 Jun; 95(6):2527-8. PubMed ID: 20525903
[TBL] [Abstract][Full Text] [Related]
10. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer.
Mandel SJ; Shankar LK; Benard F; Yamamoto A; Alavi A
Clin Nucl Med; 2001 Jan; 26(1):6-9. PubMed ID: 11139058
[TBL] [Abstract][Full Text] [Related]
11. The nonimpact of thyroid stunning: remnant ablation rates in 131I-scanned and nonscanned individuals.
Morris LF; Waxman AD; Braunstein GD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3507-11. PubMed ID: 11502771
[TBL] [Abstract][Full Text] [Related]
12. Is thyroid stunning clinically relevant? A retrospective analysis of 208 patients.
Etchebehere EC; Santos AO; Matos PS; Assumpção LV; Lima MC; Lima MC; Ward LS
Arq Bras Endocrinol Metabol; 2014 Apr; 58(3):292-300. PubMed ID: 24863093
[TBL] [Abstract][Full Text] [Related]
13. [Pathological thyroid uptake in Cushing's syndrome: an unexpected finding].
Civantos Modino S; Montaño Martínez J; Pavón de Paz I; Guijarro de Armas G; Monereo Megías S
Endocrinol Nutr; 2011; 58(6):315-7. PubMed ID: 21497569
[No Abstract] [Full Text] [Related]
14. 131I treatment of thyroid papillary carcinoma in a patient with renal failure.
Morrish DW; Filipow LJ; McEwan AJ; Schmidt R; Murland KR; von Westarp C; Betcher KB
Cancer; 1990 Dec; 66(12):2509-13. PubMed ID: 2249192
[TBL] [Abstract][Full Text] [Related]
15. Post-operative diagnosis and therapy of thyroid carcinoma by nuclear medicine.
Hundeshagen H
Eur J Nucl Med; 1983; 8(12):541-5. PubMed ID: 6667704
[No Abstract] [Full Text] [Related]
16. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
Rashid K; Johns W; Chasse K; Walker M; Gupta SM
Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
[No Abstract] [Full Text] [Related]
17. Thyroid carcinoma metastatic to pituitary.
Sziklas JJ; Mathews J; Spencer RP; Rosenberg RJ; Ergin MT; Bower BF
J Nucl Med; 1985 Sep; 26(9):1097. PubMed ID: 4032051
[No Abstract] [Full Text] [Related]
18. Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.
Cholewinski SP; Yoo KS; Klieger PS; O'Mara RE
J Nucl Med; 2000 Jul; 41(7):1198-202. PubMed ID: 10914909
[TBL] [Abstract][Full Text] [Related]
19. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
[TBL] [Abstract][Full Text] [Related]
20. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.
Muratet JP; Daver A; Minier JF; Larra F
J Nucl Med; 1998 Sep; 39(9):1546-50. PubMed ID: 9744340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
